Use of an electronic medical record to detect patients at high risk of metformin-induced lactic acidosis.
The Notes section welcomes the following types of contributions: (1) practical innovations or solutions to everyday practice problems, (2) substantial updates or elaborations on work previously published by the same authors, (3) important confirmations of research findings previously published by others, and (4) short research reports, including practice surveys, of modest scope or interest. Notes should be submitted with AJHP's manuscript checklist. The text should be concise, and the number of references, tables, and figures should be limited.
Dunham
Daniel P
DP
Division of General Internal Medicine, Feinberg School of Medicine, Northwestern University, 676 North St. Clair 18-200, Chicago, IL.60611, USA. ddunham@nmff.org
Baker
David
D
D000140:Acidosis, Lactic / Q000139:chemically induced* / Q000517:prevention & control*; D000368:Aged; D003404:Creatinine / Q000097:blood; D003920:Diabetes Mellitus / Q000188:drug therapy; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D016347:Medical Records Systems, Computerized; D008687:Metformin / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D051436:Renal Insufficiency, Chronic / Q000150:complications
D007004:Hypoglycemic Agents; D008687:Metformin; D003404:Creatinine